Section 16(a) Beneficial Ownership Reporting Compliance Security Ownership of Certain Beneficial Owners and Management Stockholder Communications with the Board of DirectorsĬompensation Committee Interlocks and Insider ParticipationĬERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS Meetings of the Board of Directors, Board and Committee Member Attendance and REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS 2Ratification of Selection of Independent Registered Public QUESTIONS AND ANSWERS ABOUT THIS PROXY MATERIAL AND IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER Statement and FOR the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm as described in Proposal No. 2 of the Proxy Statement. Our Board of Directors recommends that you vote FOR the election of the director nominees named in Proposal No. 1 of the Proxy Please review the instructions on the proxy card or the information forwarded by your bank, broker or other holder of record regarding each of these voting options. Voting over the Internet, by telephone or by written proxy will ensure your shares are represented at the Annual Internet, by telephone or by completing and mailing a proxy card or the form forwarded by your bank, broker or other holder of record. It is important that your shares be represented and voted whether or not you plan to attend the Annual Meeting in person.
The Notice of Internet Availability of Proxy Materials also provides the date, time and location of the Annual Meeting the matters to beĪcted upon at the meeting and the recommendation from our Board of Directors with regard to each matter and information on how to attend the meeting.
The Notice of Internet Availability of Proxy Materials contains instructions for accessing the proxy materials, including the Proxy StatementĪnd our annual report, and provides information on how stockholders may obtain paper copies free of charge. Electronic delivery of our proxy materials will significantly reduce our printing and mailing costs, and the environmental impact of the proxy materials.
We are also providing access to our proxy materials over the Internet beginning on or aboutĪpril 29, 2016. Internet Availability of Proxy Materials on or about May 9, 2016 to our stockholders of record as of the close of business on the Record Date. Consequently, stockholders will not receive paper copies of our proxy materials, unless they specifically request them. Only stockholders who owned our common stock at the close ofīusiness on April 25, 2016 (the Record Date) can vote at this meeting or any adjournments that take place.Įlected to use the Internet as our primary means of providing our proxy materials to stockholders. The foregoing items of business are more fully described in the Proxy Statement. To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
To ratify the selection, by the audit committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the Companys fiscal year ending To elect three directors to hold office until the 2019 annual meeting of stockholders or until their successors are elected Headquarters located at 800 Chesapeake Drive, Redwood City, California 94063 for the following purposes: Meeting) of OncoMed Pharmaceuticals, Inc., a Delaware corporation (referred to herein as the ∼ompany, we or our), will be held on June 22, 2016, at 8:00 a.m. NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders (the ∺nnual Stockholders of OncoMed Pharmaceuticals, Inc.:
Number, or the Form or Schedule and the date of its filing.įorm, Schedule or Registration Statement No.: Identify the previous filing by registration statement Proposed maximum aggregate value of transaction:įee paid previously with preliminary materials.Ĭheck box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filingįee is calculated and state how it was determined): Title of each class of securities to which transaction applies:Īggregate number of securities to which transaction applies: Payment of Filing Fee (Check the appropriate box):įee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (Name of Person(s) Filing Proxy Statement, if Other Than The Registrant) (Name of Registrant as Specified In Its Charter) Proxy Statement Pursuant to Section 14(a) of theĬonfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Table of Contents